Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-173.02%
operating margin TTM
-149.65%
revenue TTM
107.51 Million
revenue per share TTM
0.85$
valuation ratios | |
|---|---|
| pe ratio | -3.86 |
| peg ratio | -0.13 |
| price to book ratio | -2.44 |
| price to sales ratio | 5.51 |
| enterprise value multiple | -2.80 |
| price fair value | -2.44 |
profitability ratios | |
|---|---|
| gross profit margin | 90.71% |
| operating profit margin | -149.65% |
| pretax profit margin | -171.95% |
| net profit margin | -173.02% |
| return on assets | -47.0% |
| return on equity | 65.27% |
| return on capital employed | -52.93% |
liquidity ratios | |
|---|---|
| current ratio | 4.09 |
| quick ratio | 4.02 |
| cash ratio | 3.42 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 237.11 |
| operating cycle | 380.23 |
| days of payables outstanding | 262.88 |
| cash conversion cycle | 117.35 |
| receivables turnover | 2.55 |
| payables turnover | 1.39 |
| inventory turnover | 1.54 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.45 |
| debt equity ratio | -1.95 |
| long term debt to capitalization | 2.08 |
| total debt to capitalization | 2.06 |
| interest coverage | -2.29 |
| cash flow to debt ratio | -0.27 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.74 |
| cash per share | 1.50 |
| operating cash flow per share | -0.74 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.27 |
| short term coverage ratios | -24.71 |
| capital expenditure coverage ratio | -2,502.95 |
Frequently Asked Questions
When was the last time ADC Therapeutics S.A. (NYSE:ADCT) reported earnings?
ADC Therapeutics S.A. (ADCT) published its most recent earnings results on 04-05-2026.
What is ADC Therapeutics S.A.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ADC Therapeutics S.A. (NYSE:ADCT)'s trailing twelve months ROE is 65.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ADC Therapeutics S.A. (ADCT) currently has a ROA of -47.0%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ADCT's net profit margin stand at?
ADCT reported a profit margin of -173.02% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ADCT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.09 in the most recent quarter. The quick ratio stood at 4.02, with a Debt/Eq ratio of -1.95.